The acquisition will see Saga integrated into Roche’s subsidiary, Foundation Medicine, which focuses on advanced genomic profiling and personalised cancer care.
Pamba brings to the role a rich combination of frontline medical experience, executive leadership, and a proven track record of driving healthcare access across Africa.
This new alliance stands out as a bold and unconventional initiative that blends healthcare innovation with creative design thinking.